Volume 125, Issue 8 pp. 2396-2400
Zuschrift

Discovery of Hepatitis C Virus NS3 Helicase Inhibitors by a Multiplexed, High-Throughput Helicase Activity Assay Based on Graphene Oxide

Hongje Jang

Hongje Jang

Department of Chemistry, KAIST, Daejeon, 305-701 (Korea)

Search for more papers by this author
Soo-Ryoon Ryoo

Soo-Ryoon Ryoo

Department of Chemistry, Seoul National University, Seoul, 151-747 (Korea)

Search for more papers by this author
Young-Kwan Kim

Young-Kwan Kim

Department of Chemistry, Seoul National University, Seoul, 151-747 (Korea)

Search for more papers by this author
Soojin Yoon

Soojin Yoon

Department of Bioscience and Biotechnology, Konkuk University, Seoul, 143-701 (Korea)

Search for more papers by this author
Henna Kim

Henna Kim

Department of Chemistry, KAIST, Daejeon, 305-701 (Korea)

Search for more papers by this author
Prof. Dr. Sang Woo Han

Prof. Dr. Sang Woo Han

Department of Chemistry, KAIST, Daejeon, 305-701 (Korea)

Search for more papers by this author
Prof. Dr. Byong-Seok Choi

Prof. Dr. Byong-Seok Choi

Department of Chemistry, KAIST, Daejeon, 305-701 (Korea)

Search for more papers by this author
Prof. Dr. Dong-Eun Kim

Prof. Dr. Dong-Eun Kim

Department of Bioscience and Biotechnology, Konkuk University, Seoul, 143-701 (Korea)

Search for more papers by this author
Prof. Dr. Dal-Hee Min

Corresponding Author

Prof. Dr. Dal-Hee Min

Department of Chemistry, Seoul National University, Seoul, 151-747 (Korea)

Department of Chemistry, Seoul National University, Seoul, 151-747 (Korea)===Search for more papers by this author
First published: 25 January 2013
Citations: 3

This work was supported by the Basic Science Research Program (2011-0017356 for D.-H. M., 2009-0092818, 2011-0020322 for B.-S. C. and 2010-0019306, 2011-0016385 for D.-E. K.), the EPB Center (2008-0062042), and by the Research Center Program (EM1202) of the Institute for Basic Science (D.-H. M.) through the National Research Foundation of Korea (NRF) funded by the Korean government (MEST).

Graphical Abstract

Ein einfaches Testsystem auf der Basis von Graphenoxid (GO) ermöglicht das Screening selektiver Inhibitoren einer Helicase des Hepatitis-C-Virus (HCV) zusammen mit Inhibitoren eines SARS-Coronavirus (SARS-CoV) (siehe Schema). In einem einzelnen Screen wurden fünf hochselektive Inhibitoren der HCV-Helicase gefunden, die ortholog zur SARS-CoV-Helicase sind. Einige dieser Treffer wurden mit dem gleichen GO-Assay validiert.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.